A Novel Compound for Alcoholism Treatment: A Translational Strategy

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 26 Sep 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Nov 2020 Results (n=47)of pooled analysis from NCT01247896 and NCT02039349 evaluaitng population pharmacokinetic model for PF-5190457, published in the Clinical Pharmacokinetics
10 Jun 2019 Results evaluating the biotransformation of PF-51904577 in vitro and from this study's sample in humans were published in the Drug Metabolism and Disposition.
02 Oct 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com